Alexander Fleming

Fleming's microbiological and pharmacological architecture centers on the discovery of natural antimicrobial substances (lysozyme and penicillin), the demonstration of biological antibiosis, and the critique of cytotoxic chemical antiseptics.

• The Principle of Selective Antibiosis: Discovering metabolic byproducts of living microorganisms that inhibit or kill bacterial pathogens without damaging host tissues or leukocytes (selective toxicity).
• The Critique of Antiseptics (WWI): Demonstrating through capillary glass cell experiments that classical chemical antiseptics (carbolic acid, iodine) are cytotoxic to host phagocytes and increase wound sepsis mortality.
• Discovery of Lysozyme (1921): Identifying an innate, broad-spectrum antimicrobial enzyme present in human bodily fluids (tears, mucus, saliva) that enzymatically hydrolyzes bacterial peptidoglycan cell walls.
• The Penicillin Phenomenon (1928): Identifying Penicillium notatum secretion of a secondary metabolite capable of lysing Gram-positive bacterial species at extreme dilution.
• Non-Toxicity Benchmark: Proving that crude penicillin filtrates produce zero detectable cytotoxic depression of human leukocyte phagocytic activity or animal tissue viability.
• Antimicrobial Resistance Prediction (1945): The earliest formal evolutionary warning that sub-therapeutic antibiotic dosing drives selective pressure for bacterial resistance.

2.1 The Halo Zone of Inhibition Kinetics

Let $C(r, t)$ be the concentration of penicillin diffusing radially through agar from a central fungal colony of radius $r_0$ with diffusion coefficient $D$:

$$\frac{\partial C}{\partial t} = D \left( \frac{\partial^2 C}{\partial r^2} + \frac{1}{r} \frac{\partial C}{\partial r} \right)$$

Let the critical minimum inhibitory concentration (MIC) required to arrest bacterial division be $C_{crit}$.

A bacterial colony achieves confluent growth only if its population density $N(t)$ reaches stationary phase before the antibiotic concentration front exceeds $C_{crit}$:

$$\frac{dN}{dt} = \mu N \left(1 - \frac{N}{K}\right) - k_{kill}(C) N$$

Where $k_{kill}(C) > \mu$ when $C(r, t) \ge C_{crit}$.

The radius of the transparent halo $R_{inhibit}$ satisfies:

$$R_{inhibit} \approx \sqrt{4 D t_{growth} \ln\left(\frac{C_0}{C_{crit}}\right)}$$

Where $C_0$ is source secretion titer. Fleming observed $R_{inhibit} \approx 20 \text{ mm}$ around the Penicillium mold.

2.2 Mechanism of Action: Peptidoglycan Transpeptidase Inhibition

Bacterial cell walls rely on the cross-linking of peptidoglycan polymers:

$$\text{Peptidoglycan Strands} + \text{D-Ala-D-Ala} \xrightarrow{\text{Transpeptidase}} \text{Cross-linked Cell Wall } (\sigma_{wall} > P_{osmotic})$$

Penicillin ($\beta$-lactam ring structure) mimics the D-alanyl-D-alanine peptide terminus:

$$\text{Penicillin} + \text{Transpeptidase} \longrightarrow [\text{Covalent Penicilloyl-Enzyme Complex}] \quad (\text{Irreversible Inhibition})$$

The inhibition blocks cross-linking while autolysins continue to cleave existing bonds:

$$\lim_{t \to \tau} \sigma_{wall}(t) < P_{turgor} \approx 20 \text{ atm} \implies \text{Osmotic Lysis / Cell Rupture (Transparent Halo)}$$

Because eukaryotic mammalian cells lack peptidoglycan cell walls, penicillin exhibits zero cellular toxicity.

3.1 The 1928 St Mary's Contaminated Culture Dish

+--------------------------------------------------------------------------+
|                     PETRI DISH (Staphylococcus aureus)                   |
|                                                                          |
|       @@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@        |
|       @@@@@ OPAQUE GOLDEN STAPHYLOCOCCUS BACTERIAL LAWN @@@@@@@@@        |
|       @@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@        |
|                                                                          |
|                         +-----------------------+                        |
|                         |    PENICILLIUM MOLD   |                        |
|                         |  (White/Green Fungus) |                        |
|                         +-----------------------+                        |
|                                     |                                    |
|                       <--- ZONE OF INHIBITION --->                       |
|                       (Clear Halo: Dissolved Bacteria)                   |
|                                     |                                    |
|       @@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@        |
|       @@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@        |
+--------------------------------------------------------------------------+

3.2 Evolutionary Trajectory of Antibiotic Resistance (Fleming's 1945 Warning)

[ Wild Bacterial Population ] ===== (Sub-therapeutic Penicillin Dose) ====> [ Sensitive Strains Killed ]
  * Varied resistance alleles                                                * Low drug concentration
          |                                                                           |
          v                                                                           v
[ Selective Survival ] <======================================================+
  * Rare mutant transpeptidase / beta-lactamase producer survives
          |
          v
[ Resistant Population Re-growth ] =====> TOTAL DRUG FAILURE (Superbugs)

• Discovery Date: September 3, 1928, at St Mary's Hospital, London.
• The 1929 Publication: "On the Antibacterial Action of Cultures of a Penicillium, with Special Reference to their Use in the Isolation of B. influenzae". Br. J. Exp. Pathol. 10 (1929): 226–236.
• In Vitro Spectrum: Demonstrated complete bactericidal and bacteriostatic activity against Staphylococcus, Streptococcus, Pneumococcus, Meningococcus, Gonococcus, and Corynebacterium diphtheriae.
• The Nobel Prize (1945): Awarded jointly with Howard Florey and Ernst Boris Chain "for the discovery of penicillin and its curative effect in various infectious diseases."
• Demographic Impact: The antibiotic revolution triggered by penicillin is estimated to have saved over 200 million human lives, extending global life expectancy by nearly two decades.

5.1 Inability to Isolate and Purify Stable Penicillin

Fleming's primary technical limitation was his lack of advanced chemical and biochemical expertise. Between 1929 and 1939, Fleming was unable to stabilize, extract, or purify penicillin from crude mold broth in concentrations viable for clinical therapy. Had Howard Florey, Ernst Chain, and Norman Heatley not intervened with modern organic extraction and freeze-drying techniques at Oxford in 1939, penicillin would have remained an abandoned laboratory curiosity.

5.2 Narrow Gram-Negative Spectrum

Penicillin G is largely ineffective against most Gram-negative bacteria (e.g., Escherichia coli, Pseudomonas aeruginosa, Salmonella, Yersinia pestis) due to the outer lipopolysaccharide membrane barrier preventing antibiotic penetration to the periplasmic transpeptidase target.

5.3 Antimicrobial Resistance Emergence

Fleming's prophetic 1945 warning was rapidly fulfilled. Within two years of the clinical introduction of penicillin, hospitals documented the emergence of penicillin-resistant Staphylococcus aureus strains expressing penicillinase ($\beta$-lactamase), which cleaves the $\beta$-lactam ring, initiating the modern global crisis of antibiotic resistance.

• Fleming, Alexander. "On the Antibacterial Action of Cultures of a Penicillium, with Special Reference to their Use in the Isolation of B. influenzae". British Journal of Experimental Pathology 10 (1929): 226–236.
• Fleming, Alexander. "On a Remarkable Bacteriolytic Element Found in Tissues and Secretions" (Lysozyme). Proceedings of the Royal Society B 93 (1922): 306–317.
• Fleming, Alexander. "The Action of Chemical and Physiological Antiseptics in a Septic Wound". The British Journal of Surgery 7 (1919): 99–129.
• Fleming, Alexander. Penicillin: Its Practical Application. London: Butterworth & Co., 1946.
• Macfarlane, Gwyn. Alexander Fleming: The Man and the Myth. Cambridge: Harvard University Press, 1984.
• Maurois, André. The Life of Sir Alexander Fleming: Discoverer of Penicillin. Trans. Gerard Hopkins. London: Jonathan Cape, 1959.
• Lax, Eric. The Mold in Dr. Florey's Coat: The Story of the Penicillin Miracle. New York: Henry Holt and Co., 2004.